These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32816634)

  • 1. 'She is like my mother': Community-based care of drug-resistant tuberculosis in rural Eswatini.
    Burtscher D; Juul Bjertrup P; Vambe D; Dlamini V; Mmema N; Ngwenya S; Rusch B; Kerschberger B
    Glob Public Health; 2021 Jun; 16(6):911-923. PubMed ID: 32816634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Task-shifting directly observed treatment and multidrug-resistant tuberculosis injection administration to lay health workers: stakeholder perceptions in rural Eswatini.
    Peresu E; Heunis JC; Kigozi NG; De Graeve D
    Hum Resour Health; 2020 Dec; 18(1):97. PubMed ID: 33272307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient satisfaction with directly observed treatment and multidrug-resistant tuberculosis injection administration by lay health workers in rural Eswatini.
    Peresu E; Heunis CJ; Kigozi GN; De Grave D
    Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e10. PubMed ID: 32501027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful expansion of community-based drug-resistant TB care in rural Eswatini - a retrospective cohort study.
    Kerschberger B; Telnov A; Yano N; Cox H; Zabsonre I; Kabore SM; Vambe D; Ngwenya S; Rusch B; Tombo ML; Ciglenecki I
    Trop Med Int Health; 2019 Oct; 24(10):1243-1258. PubMed ID: 31390108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitudes and practices of community treatment supporters administering multidrug-resistant tuberculosis injections: A cross-sectional study in rural Eswatini.
    Peresu E; Heunis JC; Kigozi NG; De Graeve D
    PLoS One; 2022; 17(7):e0271362. PubMed ID: 35834492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
    Peresu E; De Graeve D; Heunis JC; Kigozi NG
    PLoS One; 2024; 19(4):e0301507. PubMed ID: 38564589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan.
    Burtscher D; Van den Bergh R; Toktosunov U; Angmo N; Samieva N; Rocillo Arechaga EP
    PLoS One; 2016; 11(3):e0152283. PubMed ID: 27019454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda.
    Makabayi-Mugabe R; Musaazi J; Zawedde-Muyanja S; Kizito E; Fatta K; Namwanje-Kaweesi H; Turyahabwe S; Nkolo A
    BMC Health Serv Res; 2023 Nov; 23(1):1248. PubMed ID: 37957610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Gradmann C; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e035272. PubMed ID: 32554739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative evaluation of hospital versus community-based management of patients on injectable treatments for tuberculosis.
    Cohen DB; Phiri M; Banda H; Squire SB; Namakhoma I; Desmond N
    BMC Public Health; 2018 Sep; 18(1):1127. PubMed ID: 30223808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
    Benbaba S; Isaakidis P; Das M; Jadhav S; Reid T; Furin J
    PLoS One; 2015; 10(12):e0144936. PubMed ID: 26713873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "They have been neglected for a long time": a qualitative study on the role and recognition of rural health motivators in the Shiselweni region, Eswatini.
    Walker C; Burtscher D; Myeni J; Kerschberger B; Schausberger B; Rusch B; Dlamini N; Whitehouse K
    Hum Resour Health; 2020 Sep; 18(1):66. PubMed ID: 32958066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The introduction of video-enabled directly observed therapy (video-DOT) for patients with drug-resistant TB disease in Eswatini amid the COVID-19 pandemic - a retrospective cohort study.
    Kerschberger B; Daka M; Shongwe B; Dlamini T; Ngwenya S; Danbakli C; Mamba B; Nxumalo B; Sibanda J; Dube S; Dlamini LM; Mabhena E; Mukooza E; Crumley I; Ciglenecki I; Vambe D
    BMC Health Serv Res; 2024 Jun; 24(1):699. PubMed ID: 38831356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lived experiences of patients and families with decentralised drug-resistant tuberculosis care in the Eastern Cape, South Africa.
    Iruedo JO; Pather MK
    Afr J Prim Health Care Fam Med; 2023 Dec; 15(1):e1-e16. PubMed ID: 38197684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic Management of Drug-Resistant Tuberculosis: A Qualitative Analysis of Human Resource Constraints in a Resource-Limited Country context-Ethiopia.
    Mussie KM; Gradmann C; Yimer SA; Manyazewal T
    Int J Public Health; 2021; 66():633917. PubMed ID: 34434083
    [No Abstract]   [Full Text] [Related]  

  • 18. Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013.
    Verdecchia M; Keus K; Blankley S; Vambe D; Ssonko C; Piening T; Casas EC
    PLoS One; 2018; 13(10):e0205601. PubMed ID: 30332452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    Loveday M; Hlangu S; Furin J
    PLoS One; 2020; 15(12):e0242604. PubMed ID: 33347448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Yimer SA; Manyazewal T; Gradmann C
    PLoS One; 2019; 14(11):e0224277. PubMed ID: 31721767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.